UNSPSC 51393308: Laprafylline

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51393308

Definition

This classification denotes a bronchodilator with the molecular formula C29H36N6O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F427P36M7J, chemically known as 1-methyl-3-isobutyl-8-(2-ethyl(1-(4-diphenylmethylpiperazinyl)))-3,7-dihydro-(1h)-purine 2,6-dione but generally known as laprafylline, which bears US NIH Compound Identifier 65821. European Medicines Agency schedules Laprafylline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08405MIG.

Read the full definition

The term LAPRAFYLLINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, No. 3, 1989, List 29). LAPRAFYLLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule laprafylline under HS 29395900 and SITC 54145. As of Q4 2014, LAPRAFYLLINE remains the US FDA Preferred Term for this commodity. Laprafylline bears US NLM identifiers UMLS ID C0073782 and NCI Concept Code C96198. SMILES: O=C1N(C(=O)N(C2NC([NH]C12)CCN1CCN(CC1)C(C1CCCCC1)C1CCCCC1)CC(C)C)C.

About UNSPSC 51393308

UNSPSC 51393308 Laprafylline is a Commodity code that does not align with the recent state and local procurement activity posted under it. The sole opportunity in the dataset—Seminole County, Florida's IFB 60459723LAS for naloxone and drug deactivation systems—addresses pharmaceutical harm-reduction products and public health supply procurement, not laprafylline (a methylxanthine pharmaceutical compound). The mismatch suggests either a classification error in the source data or a narrow misalignment between the code's nominal scope and the actual work being solicited. State and local procurement records show no additional recent opportunities under this code.

Seminole County's naloxone procurement released on June 30, 2026, with a due date of July 26, 2026, sought 1,900 units of naloxone and 800 safe drug deactivation systems annually on a two-year term with one-year renewal option, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The IFB required electronic submission through the county's e-Procurement Portal, included all shipping and delivery costs in vendor proposals, mandated E-Verify compliance and drug-free workplace certification, and carried a three-month probationary period permitting termination at will. The procurement carried potential FEMA funding with associated federal compliance requirements. The code shows no documented activity from other issuing bodies, states, or recent response windows that would support broader geographic or jurisdictional characterization.

Quick answers

What is UNSPSC 51393308?

UNSPSC 51393308 is Laprafylline, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51393308?

UNSPSC 51393308 maps to 1 NIGP code, 26912 Autonomic Drugs.

On GovTribe

See everything under UNSPSC 51393308

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code